Aug 13, 2020
Regulus Therapeutics Reports Second Quarter 2020 Financial Results and Recent Updates
May 18, 2020
Regulus Cyber Raises $4M After Signing Deal With Automotive Tier 1 and Expanding GPS Cybersecurity Product Capabilities
May 14, 2020
Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates
Mar 12, 2020
Regulus Reports Fourth Quarter and Year-End 2019 Financial Results and Recent Updates
Sep 03, 2019
Regulus Therapeutics to Present at the H.C. Wainwright Global Investment Conference
Aug 08, 2019
Regulus Therapeutics Reports Second Quarter 2019 Financial Results and Recent Updates
Jul 23, 2019
Regulus Therapeutics Announces RGLS4326 Program Update
Jun 11, 2019
Regulus Announces New Additions to Board of Directors
May 09, 2019
Regulus Therapeutics Reports First Quarter 2019 Financial Results and Recent Updates
May 06, 2019
Regulus Therapeutics Announces Restructuring of Term Loan
Mar 15, 2019
Regulus Announces Transition of Research Leadership
Nov 08, 2018
Regulus Reports Third Quarter 2018 Financial Results and Recent Updates
Oct 25, 2018
Regulus to Present Data from ATHENA, a Global Natural History of Disease Study for Alport Syndrome, at ASN's Kidney Week 2018
Sep 26, 2018
Regulus Provides Pipeline Updates
Jul 05, 2018
Regulus Announces Strategic Update and Corporate Restructuring
May 02, 2018
Regulus Cyber Wins AUVSI XCELLENCE Award
May 01, 2018
Regulus Cyber Raises $6.3M to Ensure Security & Mission Reliability for Autonomous Cars & Trucks, Robots, and Drones
May 01, 2018
Regulus Initiates Multiple Ascending Dose Study in Healthy Volunteers of RGLS4326 for the Treatment of ADPKD
Apr 17, 2018
Kathryn J. Collier Joins Regulus Board of Directors
Mar 07, 2018
Regulus Reports Fourth Quarter and Year-end 2017 Financial Results and Pipeline Update